Co-localization of activating transcription factor 3 and phosphorylated c-Jun in axotomized facial motoneurons by Park, Byung Gu et al.
Original Article
Corresponding author: 
Byung Pil Cho
Department of Anatomy, Yonsei University Wonju College of 
Medicine, 162 Ilsan-dong, Wonju 220-701, Korea
Tel: +82-33-741-0272, Fax: +82-33-742-1434, E-mail: bpcho@yonsei.ac.kr
*Byung Gu Park and Jin Sook Lee contributed equally to this work.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which 
permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2011. Anatomy and Cell Biology
http://dx.doi.org/10.5115/acb.2011.44.3.226
pISSN 2093-3665   eISSN 2093-3673
Co-localization of activating transcription 
factor 3 and phosphorylated c-Jun in 
axotomized facial motoneurons
Byung Gu Park
1, Jin Sook Lee
1, Ji Yong Lee
1, Dae Yong Song
2, Seong-Woo Jeong
3, Byung Pil Cho
1
1Department of Anatomy, Yonsei University Wonju College of Medicine, Wonju, 
2Department of Anatomy and Neuroscience, Eulji University School of 
Medicine, Daejeon, 
3Department of Physiology, Yonsei University Wonju College of Medicine, Wonju, Korea
Abstract: Activating transcription factor 3 (ATF3) and c-Jun play key roles in either cell death or cell survival, depending 
on the cellular background. To evaluate the functional significance of ATF3/c-Jun in the peripheral nervous system, we 
examined neuronal cell death, activation of ATF3/c-Jun, and microglial responses in facial motor nuclei up to 24 weeks after an 
extracranial facial nerve axotomy in adult rats. Following the axotomy, neuronal survival rate was progressively but significantly 
reduced to 79.1% at 16 weeks post-lesion (wpl) and to 65.2% at 24 wpl. ATF3 and phosphorylated c-Jun (pc-Jun) were detected 
in the majority of ipsilateral facial motoneurons with normal size and morphology during the early stage of degeneration 
(1-2 wpl). Thereafter, the number of facial motoneurons decreased gradually, and both ATF3 and pc-Jun were identified 
in degenerating neurons only. ATF3 and pc-Jun were co-localized in most cases. Additionally, a large number of activated 
microglia, recognized by OX6 (rat MHC II marker) and ED1 (phagocytic marker), gathered in the ipsilateral facial motor 
nuclei. Importantly, numerous OX6- and ED1-positive, phagocytic microglia closely surrounded and ingested pc-Jun-positive, 
degenerating neurons. Taken together, our results indicate that long-lasting co-localization of ATF3 and pc-Jun in axotomized 
facial motoneurons may be related to degenerative cascades provoked by an extracranial facial nerve axotomy.
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ATF3, a member of the cAMP-responsive element binding 
protein/activating transcription factor (CREB/ATF) family, is 
induced by various types of tissue damage including axotomy 
[4-7]. However, the functional significance of stress-induced 
ATF3 expression is unclear due to conflicting data. Several 
investigators have proposed that ATF3 plays a protective role 
in neuronal or non-neuronal cells [8, 9]. In contrast, others 
have suggested that ATF3 is involved in cell death [4, 10, 11]. 
CREB/ATF family members have a basic region/leucine 
zipper domain that mediates their heterodimerization. ATF3 
forms heterodimers with Jun proteins to activate transcription 
of certain genes [12], but as a homodimer, it represses gene 
transcription [6]. Similar to ATF3, the role of stress-induced 
c-Jun activation is unclear. c-Jun signaling appears to be 
Introduction
Immediate early genes (IEGs) are induced in a fast and 
transient manner in the nervous system by various stimuli [1]. 
Many IEGs encode transcription factors that control specific 
target genes related to neuronal response effector functions 
[2]. Axotomy induces and activates several IEGs, including 
activating transcription factor 3 (ATF3) and c-Jun [3-5]. ATF3/pc-Jun in axotomized facial motoneurons
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involved in either cell survival or death, depending on the cell 
type and specific circumstances. Induction of c-Jun may be 
involved in neuronal protection or regeneration [1, 13, 14]; 
however, activation of c-Jun is also found in degenerating and 
apoptotic neurons [15-18], in axotomized neurons [19], and 
in biopsies from patients affected with Alzheimer's disease [20] 
and multiple sclerosis [21]. 
We previously reported co-localization of ATF3 and 
phosphorylated c-Jun (pc-Jun) in the degenerating dopamine 
(DA) neurons of the substantia nigra pars compacta after 
medial forebrain bundle (MFB) transection [4]. We also 
demonstrated that activated and phagocytic microglia 
specifically adhere to various parts of degenerating DA 
neurons throughout the entire neurodegenerative process 
[4, 22-24]. These findings strongly support the concept that 
the putative ATF3/pc-Jun heterodimer is closely related to 
axotomy-induced neurodegeneration in the central nervous 
system (CNS). However, many studies have suggested that 
activation of ATF3 and/or c-Jun is involved in neuronal 
regeneration or protection in the peripheral nervous system 
(PNS), including the central extrinsic neurons such as facial 
motoneurons [1, 9, 13, 25]. 
An extracranial facial nerve axotomy may result in delayed 
neuronal cell death in adult rats [26-28]. This finding implies 
the presence of phagocytic microglia in the facial motor 
nucleus after axotomy, because microglia respond sensitively 
to diverse neuropathological factors, even to very subtle 
alterations in their microenvironment, such as an imbalance 
in ion homeostasis that precedes detectable pathological 
change [29]. However, several authors have reported no 
phagocytic microglia in the facial motor nucleus following 
an extracranial facial nerve axotomy in adult rats [28, 30, 31]. 
Therefore, the interaction between degenerating neurons 
and microglia should be carefully investigated to verify this 
contradiction and to understand the exact pathophysiology 
induced by an extracranial facial nerve axotomy. Additionally, 
as an extracranial facial nerve axotomy induces slow and 
long-lasting neurodegeneration [26, 27], it is necessary to 
analyze microglial behavior and function over an extended 
period of time.
This study was performed to elucidate the functional 
significance of stress-induced activation of ATF3 and c-Jun 
in axotomized facial motoneurons. We examined temporal 
and spatial profiles of these IEGs in the facial motor nucleus 
after an extracranial facial nerve axotomy in adult rats. 
We also investigated the survival rate and morphological 
changes of axotomized facial motoneurons up to 6 months. 
Morphological and immunophenotypical changes in 
microglia, as well as their spatial relationship with axotomized 
facial motoneurons, were carefully analyzed to assess the 
status and propagation of ongoing neurodegeneration.
Materials and Methods
Animal care and surgical procedures
Animal use and care protocols were approved by the 
Insti  tutional Animal Care and Use Committee of Yonsei 
University at Wonju Campus, Wonju, Korea. Forty adult 
male Wistar rats (body weight, 250-300 g; Charles River Lab., 
Wilmington, MA, USA) were used. All efforts were made 
to minimize the number of animals required and to ensure 
minimal suffering of animals. Rats were housed with free 
access to food and water in a room maintained at constant 
room temperature (20-22°C) with a 12 : 12-hour light-dark 
cycle. 
For the extracranial facial nerve axotomy, rats were deeply 
anesthetized with an intraperitoneal injection of ketamine 
(70 mg/kg body weight) and xylazine (8 mg/kg body weight), 
and the left facial nerve was exposed posterior to the left ear. 
The facial nerve was transected at a point 2.0 mm inferior to 
the stylomastoid foramen, and a 2.0 mm long fragment of 
the distal section was removed to avoid spontaneous union 
of the two separated parts of the nerve. After suturing of the 
skin, animals were kept on a heating plate at 37°C until they 
completely recovered. Animals were sacrificed at various time 
points between 3 days post-lesion and 24 weeks post-lesion 
(wpl). The contralateral side of the brain was used as the 
internal control, because the facial nerve does not cross the 
midline during its course to the PNS. 
Retrograde tracing with FluoroGold
To examine the spatial relationship between activated 
microglia and degenerating facial motoneurons in detail, 
various parts of axotomized facial motoneurons were detected 
by retrograde tracing using FluoroGold (FG; Fluorochrome, 
Englewood, CO, USA) at 2 wpl. Under deep anesthesia, the 
proximal segment of the transected nerve end was carefully 
exposed, and 0.1% FG dissolved in 0.9% physiological saline 
was added to the segment. Then, the overlying skin was 
sutured, and the animals were kept on a heating plate at 37°C 
until they completely recovered. The animals were sacrificed 2 Anat Cell Biol 2011;44:226-237 Byung Gu Park, et al 228
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days after the FG treatment.
Sample preparation and immunohistochemistry
All animals were deeply anesthetized as described above, 
and the thorax was opened. Animals were at first perfused 
transcardially with 100 ml of ice-cold 0.1 M phosphate buffer 
(PB; pH 7.4) containing 0.5% sodium nitrite and 10 U/ml 
heparin, then with 400 ml of 4% paraformaldehyde in 0.1 M 
PB. The brain was carefully removed from the skull and, based 
on the atlas of Paxinos and Watson [32], sliced into a block to 
contain the facial motor nucleus. The brain block was post-
fixed for 12 hours in the same fixative and was infiltrated with 
30% sucrose solution overnight at 4°C until it had submerged. 
The block was then rapidly frozen in 2-methylbutane chilled 
on dry ice and mounted in Tissue-Tek OCT compound 
(Sakura Finetechnical Co., Tokyo, Japan). Serial coronal 
sections of 40 µm thickness were obtained on a cryostat 
microtome (Leica Microsystems Inc., Wetzlar, Germany) and 
were distributed sequentially to a set of twelve tissue wells 
containing 0.1 M PB. After a brief wash with 0.1 M PB, the 
brain sections were transferred to another set of twelve tissue 
wells containing cryoprotection solution and were then stored 
in a freezer at a temperature less than -20°C until use.
The sections were washed three times with 0.1 M PB 
containing 0.9% sodium chloride and 0.1% Triton X-100 
(PBST, pH 7.4) and were treated with 3% hydrogen peroxide 
for 15 minutes to suppress endogenous peroxidase activity. 
After washing with 0.1 M PBST, the sections were treated for 
1 hour with 5% normal serum obtained from the same host 
species as the secondary antibody to reduce non-specific 
binding and were then incubated with primary antibodies 
diluted in 0.1 M PBST for 12 hours at 25°C. 
The primary antibodies used were: rabbit polyclonal 
anti-ATF3 (1 : 500, Santa Cruz Biotechnology, Santa Cruz, 
CA, USA), rabbit polyclonal anti-pc-Jun (1 : 300, Ser 63, 
Cell Signaling Technology Inc., Beverly, MA, USA), rabbit 
polyclonal anti-FG (1 : 1,000, Chemicon, Temecula, CA, 
USA), mouse monoclonal anti-neuronal nuclei (NeuN; 1 : 
500, Chemicon), mouse monoclonal anti-rat MHC II (1 : 500, 
OX6, Serotec, Oxford, UK), and mouse monoclonal anti-
rat CD68 (1 : 500, ED1, Serotec). OX6 and ED1 were used to 
identify activated microglia: ED1 labels the lysosomal enzyme, 
which is upregulated in microglia during phagocytosis [33], 
and OX6 labels rat MHC class II, which is upregulated in 
activated microglia including those that are phagocytic [4, 22, 
24, 34].
After the primary antibody incubation, the sections were 
washed three times with 0.1 M PBST and incubated for 2 
hours with biotinylated goat anti-rabbit IgG (1 : 200, Vector 
Lab., Burlingame, CA, USA) for ATF3 and pc-Jun, or with 
biotinylated horse anti-mouse IgG (1 : 200, Vector Lab.) for 
NeuN and microglia markers. After three washes, sections 
were incubated with avidin-biotin-peroxidase complex 
(ABC; Vector Lab.) for 1 hour and treated with 0.05% 
3,3'-diaminobenzidine tetrahydrochloride (DAB; Sigma-
Aldrich, St. Louis, MO, USA) containing 0.01% hydrogen 
peroxide for 5 minutes to detect peroxidase activity. Sections 
were mounted on gelatin-coated slides, counterstained with 
0.1% cresyl violet (Sigma-Aldrich), dehydrated through a 
graded ethanol series, cleared in xylene, and covered with 
coverslips using Permount. 
Multiple immunohistochemistry
Multiple immunohistochemistry was performed as 
previously described [22]. Briefly, each labeling step was 
performed sequentially using the peroxidase ABC method, 
and possible cross reactions between immunological reac-
tions against primary antibodies derived from the same 
host species were blocked using unconjugated Fab IgG. For 
double immunohistochemical labeling of ED1 (or FG) and 
OX6, sections were first stained with ED1 (or FG) using 
DAB-nickel (black reaction product; Vector Lab.), and then 
with OX6 using DAB (brown reaction product). Because the 
spatial relationship between activated microglia and damaged 
neurons could provide meaningful data on the outcome of 
neurons, some sections were triple-labeled with antibodies 
for pc-Jun, OX6, and NeuN. In such cases, sections were first 
stained with anti-pc-Jun antibody using DAB-nickel, then 
with OX6 using DAB, and finally with anti-NeuN antibody 
using VIP (purple reaction product; Vector Lab.). 
Double immunofluorescence labeling
Co-localization of ATF3 and pc-Jun was examined by 
indirect immunofluorescence. Sections were first incubated 
with 10% normal goat serum for 1 hour, followed by an 
incubation with anti-pc-Jun antibody (1 : 30) for 12 hours at 
4°C. After rinsing in PBS, Cy3-conjugated goat anti-rabbit 
IgG (1 : 250, Jackson ImmunoResearch Lab., West Grove, PA, 
USA) was applied for 2 hours at room temperature. Sections 
were rinsed and then incubated first with 10% normal rabbit 
serum for 1 hour and then with an excess of unconjugated 
Fab goat anti-rabbit IgG (1 : 20, Jackson ImmunoResearch ATF3/pc-Jun in axotomized facial motoneurons
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Lab.) for 1 hour to block the activity of the first antibody. The 
sections were then incubated with anti-ATF3 antibody (1 : 50) 
for 12 hours, biotinylated goat anti-rabbit IgG (1 : 200) for 2 
hours, and FITC-conjugated avidin D (1 : 50, Vector Lab.) for 
1 hour at room temperature. Finally, the sections were rinsed 
in PBS and mounted with Vectashield (Vector Lab.). 
Cell count
The number of facial motoneurons was counted on 
coronal sections stained with cresyl violet. Two of 12 sets of 
samples were randomly chosen from each animal and were 
mounted on gelatin-coated slides after three washes with 
0.1 M PB. After staining with 0.1% cresyl violet, the samples 
were dehydrated through a graded ethanol series, cleared in 
xylene, and covered with coverslips. Light photomicrographic 
images were acquired on a Nikon Optiphot microscope 
(Nikon Inc., Tokyo, Japan) fitted with a Nikon digital camera 
(DXM1200), using Nikon ACT-1 image capture software 
(ver. 2.2). These images were imported into Adobe Photoshop 
(ver. 7.0, Adobe Systems Inc., San Jose, CA, USA) and were 
adjusted for brightness and contrast to optimize photographic 
representation of the images obtained by the microscope. 
All neurons on both sides of the facial motor nucleus 
were counted with the analySIS (Olympus Soft Imaging 
Fig. 1. (A-F) Facial motoneurons stained with cresyl violet on the contralateral (A) and ipsilateral (B-F) sides. Significant loss of facial motoneurons 
was clearly identified from 16 weeks (w) post-lesion (E, F). Cont, contralateral. Scale bar=100 µm (A-F). (G) Survival rates of ipsilateral facial 
motoneurons compared to the corresponding contralateral side. *P<0.05, 
†P<0.01.Anat Cell Biol 2011;44:226-237 Byung Gu Park, et al 230
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System, Münster, Germany) image analyzer system, and the 
percentages of ipsilateral facial motoneurons compared to 
the corresponding contralateral facial motoneurons were 
calculated. In addition, the number of ATF3- and pc-Jun-
positive neurons in the ipsilateral facial motor nucleus was 
similarly counted using immunohistochemically stained 
coronal sections, and their percentages to the total number of 
facial motoneurons on the same side were obtained. 
Data analysis
 t-tests and a repeated-measures analysis of variance 
were performed to statistically analyze the number of facial 
motoneurons. An univariate analysis was also performed 
using an F-test in which the degrees of freedom were adjusted 
to a smaller value using Huynh-Feldt methods. A value of 
P<0.05 was considered statistically significant. 
Results
Loss of facial motoneurons following the extracranial 
facial nerve axotomy
Following the extracranial facial nerve axotomy, the 
number of facial motoneurons gradually and consistently 
decreased until 24 weeks (Fig. 1). Compared to the corre-
sponding contralateral facial motoneurons, survival rates of 
the ipsilateral neurons were 102.1%, 94.7%, 93.4%, 88.0%, 
79.1%, and 65.2% at 1, 2, 4, 8, 16, and 24 wpl, respectively. 
The neuronal loss was not statistically significant until 8 wpl, 
but it became significant at 16 and 24 wpl (Fig. 1G). The 
shape and size of the ipsilateral neurons were similar to those 
of the contralateral neurons up to 4 wpl (Fig. 1A-C), but 
many neurons found at later time points showed shrunken 
morphology with a markedly reduced soma size (Fig. 1D-F).
Co-localization of ATF3 and pc-Jun in axotomized 
facial motoneurons
The ipsilateral facial motor nucleus revealed specific ATF3 
and pc-Jun localization patterns, but neither ATF3- nor pc-
Jun-positive neurons were found on the contralateral side (Fig. 
2). The extracranial facial nerve axotomy triggered a prompt 
induction and activation of ATF3 and c-Jun in the nuclei of 
axotomized neurons, leading to the prevalence of ATF3- and 
pc-Jun-positive nuclei in the ipsilateral facial motor nucleus. 
The majority of ipsilateral facial motoneurons became ATF3- 
and pc-Jun-positive by 2 wpl, and the number of ATF3- 
and pc-Jun-positive neurons then decreased progressively. 
In general, the distribution patterns, as well as the temporal 
profiles of ATF3-positive neurons (Fig. 2B-F), were very 
similar to those of pc-Jun-positive neurons (Fig. 2H-L), but 
the number of ATF3-positive neurons was always greater than 
that of pc-Jun-positive neurons (Fig. 2M). The percentages 
of ATF3-positive neurons were 90.1% (1 wpl), 91.9% (2 wpl), 
72.6% (4 wpl), 42.6% (8 wpl), 25.8% (16 wpl), and 21.0% (24 
wpl) of the corresponding ipsilateral facial motoneurons. 
The percentages of pc-Jun-positive neurons were 73.7% (1 
wpl), 82.2% (2 wpl), 64.2% (4 wpl), 26.2% (8 wpl), 9.1% (16 
wpl), and 0.1% (24 wpl) of the corresponding ipsilateral facial 
motoneurons (Fig. 2M). 
By 2 wpl, the size and shape of ATF3- and pc-Jun-positive 
neurons were very similar to those of the contralateral 
neurons (Fig. 2A-C, 2G-I). Thereafter, however, ATF3 and 
pc-Jun were found in neurons showing degenerative features, 
such as shrunken soma and condensed nuclei (Fig. 2D-F, 2J-
L). From 8 wpl onward, ATF3 and pc-Jun were identified in 
the majority of small-sized degenerating neurons (arrowheads 
in insets of Fig. 2E, F, K, L), whereas ipsilateral neurons 
with normal size and morphology were both ATF3- and pc-
Jun-negative (arrows in insets of Fig. 2E, F, K, L). Double 
immunofluorescence labeling demonstrated co-localization of 
ATF3 and pc-Jun in the same axotomized facial motoneurons 
in most cases, with the exception of a few cells that were 
exclusively ATF3- or pc-Jun-positive (Fig. 3).
Activated microglia in response to axotomy-induced 
neurodegeneration and their relationship with pc-
Jun-positive facial motoneurons
Numerous OX6-positive microglia were found in the 
ipsilateral facial motor nucleus, whereas no OX6-positive 
microglia were present on the contralateral side (Fig. 4). A few 
OX6-positive microglia occurred in the ipsilateral facial motor 
nucleus as early as 1 wpl (Fig. 4B). Thereafter, the number of 
OX6-positive microglia increased dramatically until 8 wpl 
and then subsequently decreased progressively; however, 
the presence of OX6-positive microglia was still identifiable 
until 24 wpl (Fig. 4C-F). All OX6-positive microglia retained 
an “activated form,” as they showed a ramified form with 
enlarged somas and thickened processes. Many of the OX6-
positive, activated microglia tightly wrapped and/or stuck 
to the axotomized facial motoneurons throughout the entire 
duration of the experiment (arrows in insets of Fig. 4C, D, F): 
this phenomenon was particularly prominent at 8 wpl (Fig. ATF3/pc-Jun in axotomized facial motoneurons
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Fig. 2. (A-L) Localization of activating transcription factor 3 (ATF3) (A-F) and phosphorylated c-Jun (pc-Jun) (G-L) in axotomized facial 
motoneurons. (A, G) Contralateral, (B-F, H-L) ipsilateral side. Both ATF3 and pc-Jun were localized in the nuclei of numerous, normal-sized 
neurons by 2 weeks (w) post-lesion (B, C, H, I), then the numbers of ATF3- and pc-Jun-positive nuclei decreased progressively (D-F, J-L). At 
later time points, long-lasting activation of ATF3 and c-Jun was found predominantly in degenerating neurons with severely shrunken soma and 
condensed nuclei (arrowheads in insets of E, F, K, L) but not in neurons with normal morphology and soma size (arrows in insets of E, F, K, L). 
Cont, contralateral. Scale bars in (F, L)=100 mm (A-L); insets of (F, L)=20 µm (B, E, F, H, K, L). (M) Percentages of ATF3- and pc-Jun-positive 
neurons compared to the corresponding ipsilateral facial motoneurons.Anat Cell Biol 2011;44:226-237 Byung Gu Park, et al 232
www.acbjournal.org http://dx.doi.org/10.5115/acb.2011.44.3.226
4D).
Retrograde tracing with FG was performed at 2 wpl to 
obtain a more detailed spatial relationship between activated 
microglia and axotomized facial motoneurons. In these 
animals, various parts of some axotomized neurons were 
clearly identified by FG immunohistochemistry. Double 
labeling of FG with OX6 revealed that OX6-positive microglia 
simultaneously adhered to axons, dendrites, and cell bodies of 
FG-positive, axotomized facial motoneurons (Fig. 4G-I).
Double immunohistochemistry for ED1 and OX6 was 
performed to identify whether the OX6-positive microglia 
were phagocytic (Fig. 5A-F). Double labeling revealed 
that all OX6-positive microglia contained numerous ED1-
positive particles (arrows in Fig. 5A-F), demonstrating that 
OX6-positive, activated microglia retain phagocytic activity. 
Additionally, to deduce the functional significance of ATF3 
and pc-Jun, the spatial relationship between activated 
microglia and axotomized facial motoneurons was examined 
by triple labeling of pc-Jun, NeuN, and OX6 (Fig. 5G-I). 
This experiment clearly demonstrated that axotomized facial 
motoneurons characterized by nuclear phosphorylation of 
c-Jun were undergoing active phagocytosis by OX6-positive 
microglia (arrows in Fig. 5H, I). 
Discussion 
The survival rates of injured neurons in the central nucleus 
branching into peripheral nerves are highly variable and de-
pend upon the type of injury, distance from the injured site 
to the origin, and age of the animal. In general, the viability 
of facial motoneurons transected or crushed outside the 
skull in adult rats is much greater than the viability after an 
intracranial axotomy of the facial nerve [28], combined ricin/
crush lesions outside the skull in adult rats [34], extracranial 
axotomy in newborn rats [30], or an extracranial axotomy 
in aging rats [27]. Some authors have proposed that an 
extracranial facial nerve axotomy in adult rats does not 
induce significant neuronal cell death but rather allows the 
affected motoneurons to regenerate [30, 31]. However, others 
have reported a significant reduction in the number of facial 
motoneurons following an extracranial axotomy in adult 
rats. Guntinas-Lichius et al. [26] found 22% neuronal cell 
death at 8 wpl and 41% at 16 wpl following an extracranial 
facial nerve axotomy, whereas Mattsson et al. [28] reported 
that 28% of the facial motoneurons were lost 4 weeks after an 
axotomy in adult rats. Furthermore, Johnson and Duberley 
[27] estimated that 17% and 25% of motoneurons undergo 
cell death by 3 months after a facial nerve transection in adult 
Fischer 344 and Wistar rats, respectively. The differences in 
the rates of cell death among different studies may result from 
differences in surgical procedures or animal strains. In our 
study, we noted a significant reduction in the number of facial 
motoneurons from 16 wpl, with a percentage of neuronal loss 
of 20.9% at 16 wpl and 34.8% at 24 wpl. This percentage was 
generally less than that reported in previous studies [26-28]. 
ATF3 and c-Jun are rapidly induced and activated by 
stressful stimuli such as nerve injury and then act as tran-
scription factors. Induction and activation of ATF3 and/or 
c-Jun are involved in two opposing functions, i.e., neuronal 
cell death and regeneration, depending on the cell type or 
injury pattern [1, 8, 11, 16-18]. Prolonged activation of pc-
Jun and/or ATF3 may be related to cell death in the CNS [4, 
16, 18, 35]. However, the axotomy response of peripheral or 
central extrinsic neurons is very different from that of central 
intrinsic neurons [36]. ATF3 and/or pc-Jun may be involved 
Fig. 3. Co-localization of activating transcription factor 3 (ATF3) and phosphorylated c-Jun (pc-Jun) in the axotomized facial motoneurons at 
2 weeks post-lesion. ATF3 and pc-Jun were predominantly co-localized in the same neurons (arrows), with the exception of a few cells that were 
either pc-Jun-positive (double arrowheads) or ATF3-positive (arrowheads). Scale bar=20 mm.ATF3/pc-Jun in axotomized facial motoneurons
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in neuronal regeneration, neuronal survival, or axonal sprou-
ting and target reinnervation in the PNS, including the 
central extrinsic neurons [9, 25, 37, 38]. Lindwall and Kanje 
[37] proposed that injury-induced phosphorylation of c-Jun 
is accomplished by retrograde axonal transport of c-Jun 
N-terminal kinase (JNK) signaling components initiated by 
axonal damage, and that these activated transcription factors 
may, in turn, be responsible for the induction of proteins 
such as Hsp27, which are involved in neuronal survival and 
axonal sprouting. In addition, a study on JNK3-knockout 
mice and mice with a c-JunAA mutation (c-Jun with serines 
63/73 replaced by nonphosphorylable alanines) demonstrated 
that these genes do not affect the survival of facial moto-
neurons following facial nerve axotomy, in contrast to the 
neuroprotective effects for axotomized DA neurons in the 
same animal strains [39].
In this study, we examined induction and activation of 
ATF3/c-Jun in axotomized facial motoneurons. Following 
Fig. 4. (A-F) OX6 immunohistochemistry on the contralateral (A) and ipsilateral (B-F) sides. A few OX6-positive microglia were identified in the 
ipsilateral facial motor nucleus as early as 1 week (w) post-lesion (wpl) (B). The number of OX6-positive microglia increased significantly by 8 wpl 
(C, D) and subsequently decreased, but a few persisted up to 24 wpl (E, F). All OX6-positive microglia were ramified and closely adhered to or 
surrounded facial motoneurons (arrows in insets of C, D, F). (G-I) Double labeling of FluoroGold (FG) and OX6 at 2 wpl. OX6-positive microglia 
intimately adhered to the axon (arrow in G), dendrites (arrows in H), and cell bodies (arrows in I) of FG­positive, axotomized facial motoneurons.
Cont, contralateral. Scale bars in (F)=100 mm (A-F), (I)=50 mm (G-I); inset of (F)=20 mm (C, D, F).Anat Cell Biol 2011;44:226-237 Byung Gu Park, et al 234
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resection of the facial nerve outside the skull, ATF3 and pc-
Jun were quickly and specifically induced in axotomized 
facial motoneurons. The percentage of ATF3-positive neurons 
compared to the ipsilateral facial motoneurons reached 90.9% 
at 1 wpl, and then decreased gradually to 21.0% at 24 wpl. 
The percentage of pc-Jun-positive neurons compared to the 
ipsilateral neurons increased up to 82.2% by 2 wpl and then 
progressively decreased to 0.1% by 24 wpl. Interestingly, while 
temporal profiles of the two IEG-positive neurons were very 
similar to each other, ATF3-positive neurons was always 
greater in number than pc-Jun-positive neurons. 
We found that ATF3 and pc-Jun were localized in neurons 
with a normal size and shape by 2 wpl, but that at later time 
points, these IEGs were specifically found in the degenerating 
neurons with severely shrunken somas and condensed nuclei. 
These morphological features of ATF3- and pc-Jun-positive 
neurons indicate that they have already entered the execution 
stage, from which degenerating cells never return to the 
normal state [40]. Transcription factors, which normally 
function in neuronal survival or regeneration, are not likely to 
be specifically expressed in dying neurons with no possibility 
of survival. Therefore, our results strongly suggest that the 
Fig. 5. (A-F) Double labeling of OX6 (brown) and ED1 (black) followed by counterstaining with cresyl violet in the facial motor nucleus at 
various time points. All OX6-positive microglia contained ED1-positive particles or spherical bodies (arrows). These microglia closely adhered to 
the degenerating facial motoneurons throughout all degenerative stages (A-F). Some microglia were labeled by ED1 but not by OX6 (arrowheads). 
(G-I) Triple labeling of neuronal nuclei (purple), phosphorylated c-Jun (black), and OX6 (brown) in the ipsilateral facial motor nucleus at 8 weeks 
post-lesion. Numerous pc-Jun-positive facial motoneurons were closely surrounded and phagocytosed by OX6-positive microglia (arrows in H, I). d, 
days; w, weeks. Scale bars in (F)=30 mm (A­F); (G)=100 mm; (I)=50 mm (H, I).ATF3/pc-Jun in axotomized facial motoneurons
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prolonged activation of ATF3/c-Jun in axotomized facial 
motoneurons may play a role in the signal transduction 
cascades related to neurodegeneration. In accordance with 
this, ipsilateral neurons with a normal size and morphology 
observed at later time points were neither ATF3- nor pc-
Jun-positive, indicating that these IEGs had disappeared or 
had not been induced in these cells. Thus, the sharp decline 
in the number of ATF3- and pc-Jun-positive neurons after 
2 wpl could be attributed to the disappearance of these IEGs 
from the surviving neurons, as well as to axotomy-induced 
neuronal cell death.
The functional effects of pc-Jun most likely depend on the 
cellular context and may be influenced by several cofactor 
proteins or by heterodimerization partners [3, 41]. ATF3 
and c-Jun share a consensus sequence TGACTCA (TRE/
AP-1 site) and form heterodimers or homodimers through a 
basic region/leucine zipper domain [42]. Heterodimerization 
of ATF3 and c-Jun has been demonstrated by in vitro co-
immunoprecipitation studies [12]. This finding was supported 
by several in vivo co-immunolocalization studies. Concurrent 
induction/activation of ATF3 and c-Jun has been found in 
the dorsal root ganglion and spinal cord [5], retinal ganglion 
cells [25], and substantia nigra [4] after an axotomy. In the 
present study, we found that ATF3 and pc-Jun were co-
localized in degenerating facial motoneurons in most cases. 
This finding suggests that putative pc-Jun/ATF3 heterodimers 
may be associated with axotomy-induced neuronal cell death 
cascades. Because the number of ATF3-positive neurons was 
somewhat greater than that of pc-Jun-positive neurons at 
all time points examined, ATF3 was presumed to have more 
potential to dimerize with proteins other than pc-Jun. 
It has been suggested that resting microglia become 
activated but do not transform into phagocytes following 
tran  section [28, 30, 31] or crushing [34] of the facial nerve 
outside the skull in adult rats. These activated microglia 
proliferate and express strong OX42 immunoreactivity but 
lack monocyte/macrophage antigens recognized by OX41, 
ED1, ED2, Ki-M2R, or OX6. Several studies have suggested 
that the absence of ED1-positive, phagocytic microglia may 
reflect the fact that neuronal cell death following axotomy is 
minimal or that rat motoneurons do not die after facial nerve 
transection but rather regenerate in the adult facial nucleus 
[30, 31]. In these studies, survival times of the animals were 
only 6 [30] or 10 [31] days at the longest, limiting the available 
time for immunological examination with the antibodies for 
monocyte/macrophage antigens, including phagocytic marker 
ED1. In addition, Mattsson et al. [28] noted that despite the 
loss of approximately 28% of facial motoneurons at 4 weeks 
after extracranial facial nerve axotomy, no ED1-positive 
microglia were found in the facial nucleus. 
In contrast to these studies, we found numerous OX6- and 
ED1-positive microglia in the facial motor nucleus following 
an extracranial facial nerve axotomy. A few OX6-positive 
microglia were found from 1 wpl, and their number increased 
dramatically by 8 wpl but then decreased. Double label 
experiments demonstrated that all OX6-positive microglia are 
ED1-positive, i.e., phagocytic. These OX6-positive microglia 
closely surrounded the axotomized facial motoneurons, 
suggesting that they ingested the neurons through active 
phagocytosis. Retrograde tracing with FG disclosed that OX6-
positive microglia simultaneously adhered to various parts 
of axotomized facial motoneurons from the early stage of 
degeneration. The phagocytosis was particularly prominent at 
8 wpl not only because so many OX6-positive microglia were 
engulfing the neurons (Fig. 4), but also because it was followed 
by a significant reduction in the number of axotomized facial 
motoneurons (Fig. 1). Triple immunohistochemistry for pc-
Jun, NeuN, and OX6 clearly demonstrated that many neurons 
phagocytosed by OX6-positive microglia are pc-Jun-positive. 
This finding explains why both ATF3 and pc-Jun were 
localized in severely shrunken neurons at later time points 
but not in larger neurons with normal morphology. 
Our results demonstrated that extracranial facial nerve 
axotomy induces neurodegenerative changes in facial 
moto  neurons characterized by long-lasting nuclear ATF3 
ex  pression and c-Jun phosphorylation. Additionally, we 
con  firmed that ATF3- and pc-Jun-positive, degenerating 
neurons were closely surrounded by activated microglia, 
implying active phagocytosis that was directly responsible 
for the neuronal loss in the ipsilateral facial motor nucleus. 
These intracellular events and microglial responses were 
largely identical to those found in the CNS following 
MFB transection [4, 22-24], except that the progress of 
neurodegeneration induced by the extracranial facial nerve 
axotomy was much slower than that induced by a MFB 
axotomy. Taken together, our results strongly support the 
idea that long-lasting activation of ATF3 and c-Jun, which 
are putative heterodimeric partners, may be involved in the 
intracellular signaling cascades resulting in neuronal cell 
death following an extracranial facial nerve axotomy. Anat Cell Biol 2011;44:226-237 Byung Gu Park, et al 236
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